Country: United States
Language: English
Source: NLM (National Library of Medicine)
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987)
Hikma Pharmaceuticals USA Inc.
LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL
INFILTRATION
PRESCRIPTION DRUG
Lidocaine HCl Injections are indicated for production of local anesthesia by infiltration techniques such as percutaneous injection and by peripheral nerve block techniques such as brachial plexus and intercostal, when the accepted procedures for these techniques as described in standard textbooks are observed. Lidocaine HCl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.
Lidocaine Hydrochloride Injection, USP is preserved with 0.1% methylparaben and is available in the following concentrations: 1% (10 mg/ mL) 2 mL Multiple Dose Vials packaged in 25s (NDC 0143-9579-25) 30 mL Multiple Dose Vials packaged in 10s (NDC 0143-9578-10) 50 mL Multiple Dose Vials packaged in 10s (NDC 0143-9577-10) 2% (20 mg/ mL) 2 mL Multiple Dose Vials packaged in 25s (NDC 0143-9576-25) 50 mL Multiple Dose Vials packaged in 10s (NDC 0143-9575-10) Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . For Product Inquiry call 1-877-845-0689.
Abbreviated New Drug Application
LIDOCAINE- LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION HIKMA PHARMACEUTICALS USA INC. ---------- LIDOCAINE HYDROCHLORIDE INJECTION, USP PRESERVED LOCAL ANESTHETIC FOR INFILTRATION AND NERVE BLOCK NOT FOR SPINAL OR EPIDURAL ANESTHESIA RX ONLY DESCRIPTION Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic, aqueous, isotonic solution that contains a local anesthetic agent and is administered parenterally by injection. See INDICATIONS AND USAGE for specific uses. Lidocaine Hydrochloride Injection solutions contain lidocaine hydrochloride which is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride and has the molecular wt. 270.8. Lidocaine HCl (C H N O • HCl) has the following structural formula: Each mL of the 1% solution contains lidocaine hydrochloride 10 mg, sodium chloride 7 mg and 1 mg methylparaben as antiseptic preservative. Each mL of the 2% solution contains lidocaine hydrochloride 20 mg, sodium chloride 6 mg and 1 mg methylparaben as antiseptic preservative. The pH of these solutions is adjusted to approximately 5.0 to 7.0 with sodium hydroxide and/or hydrochloric acid. CLINICAL PHARMACOLOGY MECHANISM OF ACTION Lidocaine HCl stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. HEMODYNAMICS Excessive blood levels may cause changes in cardiac output, total peripheral resistance, and mean arterial pressure. With central neural blockade these changes may be attributable to block of autonomic fibers, a direct depressant effect of the local anesthetic agent on various components of the cardiovascular system. The net effect is normally a modest hypotension when the recommended dosages are not exceeded. PHARMACOKINETICS AND METABOLISM Information derived from diverse formulations, concentrations and usages reveals that lidocaine HCl is completely absorbed following parenteral administration, its rate of absorption depending, for example, upon vari Read the complete document